$45,000 of ALIGNMENT HEALTHCARE INC lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medicare Advantage"
You can find more data on corporate lobbying on Quiver Quantitative.
ALHC Insider Trading Activity
ALHC insiders have traded $ALHC stock on the open market 23 times in the past 6 months. Of those trades, 1 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $ALHC stock by insiders over the last 6 months:
- JOHN E KAO (Chief Executive Officer) has made 0 purchases and 13 sales selling 2,027,270 shares for an estimated $33,981,711.
- DAWN CHRISTINE MARONEY (President) has made 0 purchases and 5 sales selling 389,775 shares for an estimated $6,939,103.
- JOSEPH S KONOWIECKI (EVP, Corporate Affairs) has made 0 purchases and 2 sales selling 48,511 shares for an estimated $802,429.
- HYONG KIM (Chief Medical Officer) sold 35,951 shares for an estimated $713,947
- JAMES M HEAD (Chief Financial Officer) sold 11,100 shares for an estimated $233,987
- MARK D. KENT (President - MSO) purchased 14,848 shares for an estimated $197,626
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
ALHC Hedge Fund Activity
We have seen 213 institutional investors add shares of ALHC stock to their portfolio, and 115 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 11,429,608 shares (+676.3%) to their portfolio in Q2 2026, for an estimated $272,138,966
- BANK OF AMERICA CORP /DE/ added 6,131,075 shares (+190.7%) to their portfolio in Q2 2026, for an estimated $145,980,895
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 5,456,148 shares (+236.7%) to their portfolio in Q2 2026, for an estimated $129,910,883
- BLACKROCK, INC. added 5,267,759 shares (+37.4%) to their portfolio in Q2 2026, for an estimated $125,425,341
- INVESCO LTD. added 3,365,541 shares (+48.1%) to their portfolio in Q2 2026, for an estimated $80,133,531
- GOLDMAN SACHS GROUP INC added 3,001,689 shares (+296.7%) to their portfolio in Q2 2026, for an estimated $71,470,215
- POINT72 ASSET MANAGEMENT, L.P. removed 2,439,637 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $58,087,756
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
ALHC Price Targets
Multiple analysts have issued price targets for $ALHC recently. We have seen 2 analysts offer price targets for $ALHC in the last 6 months, with a median target of $19.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $16.0 on 05/26/2026
- Jonathan Yong from UBS set a target price of $22.0 on 05/01/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
